 TORONTO--BUSINESS WIRE--- HUGE FSDPharma--FSD Pharma Inc. NASDAQ: HUGE CSE: HUGE FRA: 0K9 FSD Pharma or the Company, a life sciences holding company dedicated to building a portfolio of assets and biotech solutions, announced today that Anthony Durkacz, Interim CEO of FSD Pharma, will present at the H.C. Wainwright 2nd Annual Virtual Psychedelics Conference to be held on December 6, 2021. Mr. Durkaczs presentation will be available on-demand for conference attendees starting at 7:00 a.m. ET and ac 